• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Geovax Labs (NQ: GOVX )

    1.865 +0.045 (+2.47%)
    Streaming Delayed Price Updated: 12:45 PM EST, Nov 6, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Geovax Labs

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    13 14 Next >
    GeoVax to Present at the Emerging Growth Conference on July 18, 2024
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Exposures COVID-19
    GeoVax to Present at the Emerging Growth Conference on July 18, 2024
    Company to Discuss Recent BARDA Project NextGen Award for Its Next-generation COVID-19 Vaccine and Provide Progress Update Across Its Clinical Development Pipeline 
    Via TheNewswire.com
    Exposures COVID-19
    GeoVax to Raise Approximately $3.1 Million of Gross Proceeds in Offering Priced At-the-Market
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Regulatory Compliance
    Exposures Legal Regulatory
    GeoVax to Raise Approximately $3.1 Million of Gross Proceeds in Offering Priced At-the-Market
    ATLANTA, GA - (NewMediaWire) - July 11, 2024 - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancer and infectious diseases,... 
    Via TheNewswire.com
    Topics Regulatory Compliance
    Exposures Legal Regulatory
    GeoVax Provides First Half 2024 Business Update
    Via NewMediaWire
    (GOVX) - Analyzing Geovax Labs's Short Interest
    Via Benzinga
    Why Is GeoVax (GOVX) Stock Up 110% Today?
    With Covid-19 still representing a major problem, GeoVax’s next-gen Covid vaccine may help, bolstering GOVX stock. 
    Via InvestorPlace
    Exposures COVID-19
    GeoVax to Present at BIO International Convention 2024
    Via TheNewswire.com
    Exposures COVID-19
    Why GeoVax Labs Stock Is Moving Higher Thursday
    GeoVax Labs received a BARDA Project NextGen award to conduct a study evaluating its COVID-19 vaccine candidate GEO-CM04S1. 
    Via Benzinga
    Exposures COVID-19
    GeoVax Partners with Allucent to Conduct Phase 2b Clinical Study of Next-Generation COVID-19 Vaccine Candidate with Funding from BARDA
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Exposures COVID-19
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    Pre-market stock movers are worth checking out on Thursday as we dig into all of the biggest news moving shares this morning! 
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    It's time to dive into the biggest pre-market stock movers as we check out all of the latest news happening on Wednesday morning! 
    Via InvestorPlace
    Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth
    EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GOVX),(NYSE:GSK),(NASDAQ:AZN),(NYSE:MRK) EQNX::TICKER_END 
    Via FinancialNewsMedia
    Topics Death
    Exposures Death
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth
    From FN Media Group LLC
    Via GlobeNewswire
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    GeoVax Receives BARDA Project NextGen Award to Conduct Phase 2b Clinical Study Evaluating the Company's Next-Generation COVID-19 Vaccine Candidate, GEO-CM04S1
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Exposures COVID-19
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    Pre-market stock movers are worth checking out on Friday as we dig into all of the biggest news affecting shares this morning! 
    Via InvestorPlace
    GeoVax to Present at BIO International Convention 2024
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Exposures COVID-19
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    GeoVax to Raise Approximately $1.3 Million of Gross Proceeds in Offering Priced At-the-Market
    ATLANTA, GA - (NewMediaWire) - May 17, 2024 - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancer and infectious diseases,... 
    Via TheNewswire.com
    Topics Regulatory Compliance
    Exposures Legal Regulatory
    GeoVax to Raise Approximately $1.3 Million of Gross Proceeds in Offering Priced At-the-Market
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Regulatory Compliance
    Exposures Legal Regulatory
    GOVX Stock Earnings: Geovax Labs Beats EPS for Q1 2024
    GOVX stock results show that Geovax Labs beat analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    GeoVax Reports First Quarter 2024 Financial Results and Provides Business Update
    Presented data on GEO-CM04S1 at World Vaccine Congress, delineating the unique immune system driven mechanisms that contribute to the broad efficacy of the vaccine candidate 
    Via TheNewswire.com
    GeoVax Reports First Quarter 2024 Financial Results and Provides Business Update
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19: 'Digital Medicine With Incredible Potential'
    Elon Musk has come off as a flagbearer of the mRNA technology, which is seen holding out a lot of promise by scientists. 
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    13 14 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.